Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure
Authors:
- John WikstrandJWJohn Wikstrand
- Å.KE HjalmarsonÅHÅ.KE Hjalmarson
- Finn WaagsteinFWFinn Waagstein
- B.JÖrn FagerbergBFB.JÖrn Fagerberg
- Sidney GoldsteinSGSidney Goldstein
- John KjekshusJKJohn Kjekshus
- Hans WedelHWHans Wedel
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tolerability of β-Blocker Initiation and Titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)Circulation, 2002
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- MERIT-HF - description of the trialBasic Research in Cardiology, 2000
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin.Circulation, 1989
- Determination of metoprolol in plasma and urine using high-resolution gas chromatography and electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982